Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

Verdict comes after petitions filed by Rachana Gangu and others alleged that two women lost their lives in 2021 after taking the first dose of the Covishield vaccine ...

A public health expert breaks down the most important public health issues on the agenda for the CDC's vaccine advisory ...

The Dutch health council is recommending that the age for the annual coronavirus vaccine is raised from 60 to 70 and older from the coming autumn. The number of infections, hospital admissions and ...

Feb 26 (Reuters) - ⁠The ⁠U.S. CDC's ⁠vaccine advisory committee will ​discuss and may ‌vote on recommendations ‌for issues ...

By Kamal Choudhury and Blake Brittain March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of ...

The End the Vaccine Carveout Act would expose vaccine makers to lawsuits that once drove companies out of the industry.

The company’s co-founders said they are leaving to start a new mRNA-based company.

Prasad's stint included several controversial vaccine decisions; the FDA is now searching for a new head for its vaccine division.

Earlier this month, major U.S. medical groups asked a federal judge to block the administration from implementing new guidance that cuts the number of vaccines routinely recommended for children and ...

Stanford researchers develop breakthrough nasal spray vaccine that could potentially protect against a variety of infections, ...

Following an unexpected delay of the CDC vaccine panel’s February meeting, the Advisory Committee on Immunization Practices ...